52.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
52.2.0.1 ð Cram Sheet
52.2.0.1.1 ð¥ é« yield 10
- 3 åé¡ïŒpre / hepatic / post-hepatic
- Unconjugated: hemolysis / Gilbert / Crigler-Najjar
- Conjugated: hepatocellular / cholestatic
- AST > ALT 2:1 = alcoholic
- Painless jaundice + weight loss = pancreatic Ca
- Charcot triad = cholangitis
- Reynolds pentad = + shock + altered
- Acute liver failure: INR > 1.5 + encephalopathy + < 26 wk
- Gilbert benign, fasting/stress å é
- Mirizzi: gallstone in cystic duct compress CBD
52.2.0.2 â é« yield
52.2.0.2.1 Bili Metabolism
- Heme â biliverdin â unconjugated â albumin â liver UGT â conjugated â bile â è ž â urobilinogen
- Conjugated é urineïŒdark urineïŒ
- Unconjugated äžé urine
52.2.0.2.2 Hepatitis Serology (HBV)
- HBsAg + = active infection
- Anti-HBs + = immunity (vaccine or recovered)
- Anti-HBc IgM = acute
- Anti-HBc total + HBsAg â = past infection
- HBeAg = high replication
52.2.0.2.3 Alcoholic Hepatitis Severity
- Maddrey DF: 4.6 Ã (PT - control) + bili
32 = severe â consider steroid (prednisolone 40 mg à 28d)
- MELD score
- Lille score (assess steroid response at day 7)
52.2.0.2.4 NAFLD / MASLD (22E rename)
- Steatosis without alcohol
- 25% global
- å¯é²å± NASH â cirrhosis â HCC
- FIB-4, NAFLD fibrosis score
- æ²»çïŒweight loss, GLP-1 agonist (semaglutide), resmetirom (THR-β agonist) â 22E new
52.2.0.3 ð¯ èªææª¢æž¬
- AST/ALT > 2:1? â Alcoholic
- Painless jaundice + è人 + é«é â? â Pancreatic Ca
- Charcot triad? â Fever + jaundice + RUQ â cholangitis
- Mirizzi syndrome? â Gallstone in cystic duct compress CBD
- PBC AMA? â +
- Acute liver failure criteria? â INR > 1.5 + encephalopathy + < 26 wk
- Resmetirom 22E? â MASH treatment (THR-β)
â ïž AI èçš¿ã